Co-Delivery of a High Dose of Amphotericin B and Itraconazole by Means of a Dry Powder Inhaler Formulation for the Treatment of Severe Fungal Pulmonary Infections

Over the past few decades, there has been a considerable rise in the incidence and prevalence of pulmonary fungal infections, creating a global health problem due to a lack of antifungal therapies specifically designed for pulmonary administration. Amphotericin B (AmB) and itraconazole (ITR) are two...

Descripción completa

Detalles Bibliográficos
Autores principales: Celi, Salomé S., Fernández-García, Raquel, Afonso-Urich, Andreina I., Ballesteros, M. Paloma, Healy, Anne Marie, Serrano, Dolores R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675812/
https://www.ncbi.nlm.nih.gov/pubmed/38004579
http://dx.doi.org/10.3390/pharmaceutics15112601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675812/
https://www.ncbi.nlm.nih.gov/pubmed/38004579
http://dx.doi.org/10.3390/pharmaceutics15112601

Ejemplares similares